
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1028 | 1005 | 1111 | 1176 | 1489 | 1993 |
Fund Return | 2.82% | 0.51% | 11.06% | 5.57% | 8.29% | 7.14% |
Place in category | 95 | 26 | 26 | 27 | 23 | 10 |
% in Category | 45 | 10 | 15 | 15 | 15 | 9 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
TIAA-CREF Bond Index Institutional | 11.29B | 2.72 | -0.46 | 1.40 | ||
TIAA-CREF Lifecycle Index 2040 Inst | 9.32B | 2.94 | 7.45 | 8.54 | ||
TIAA-CREF Lifecycle Index 2035 Inst | 8.76B | 2.88 | 6.40 | 7.81 | ||
TIAA-CREF Lifecycle Index 2045 Inst | 7.98B | 2.95 | 8.03 | 9.06 | ||
TIAA-CREF Lifecycle Index 2050 Inst | 6.88B | 2.95 | 8.28 | 9.24 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
The Vanguard Target Retire 2030 Tr1 | 108.65B | 2.50 | 5.44 | 6.95 | ||
The Vanguard Target Retire 2030 Tr2 | 108.65B | 2.51 | 5.43 | 6.93 | ||
Vanguard Target Retire Trust Plus30 | 108.65B | 2.49 | 5.45 | 6.95 | ||
Vanguard Target Retirement 2030 Inv | 98.26B | 2.48 | 5.37 | 6.86 | ||
American Funds 2030 Trgt Date RetR6 | 34.53B | 3.18 | 5.92 | 7.63 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Nuveen Equity Index W | - | 37.77 | - | - | |
Nuveen Bond Index W | - | 33.86 | - | - | |
Nuveen International Eq Idx W | - | 14.16 | - | - | |
Nuveen Emerging Markets Eq Idx W | - | 6.40 | - | - | |
Nuveen Inflation Link Bd W | - | 3.86 | - | - |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Neutral | Buy |
Technical Indicators | BUY | Neutral | Strong Buy |
Summary | Neutral | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review